by The global Preclinical Imaging Market consists of technologies such as optical imaging systems, nuclear imaging systems, micro-MRI systems, micro-CT systems, micro-ultrasound systems, and preclinical photoacoustic imaging systems. Preclinical imaging equipment are widely used in biological, pharmaceutical, and chemical research applications. These systems help researchers visualize molecular and biological processes in living subjects in a non-invasive and longitudinal manner. The growing interest in personalized medicine and biomarker research has fueled the demand of preclinical imaging globally.
The Global Preclinical Imaging Market is estimated to be valued at US$ 4.25 BN in 2024 and is expected to exhibit a CAGR of 5.2% over the forecast period from 2024 to 2031.
Key Takeaways
Key players operating in the global Preclinical Imaging Market are Bruker Corporation, Siemens A.G., General Electric (GE), TriFoil Imaging, PerkinElmer, Inc., VisualSonics Inc. (Fujifilm), Inc., Mediso Ltd., Agilent Technologies, MILabs B.V., MR Solutions, and Molecubes.
The Preclinical Imaging Market Demand is growing rapidly due to their wide applications in drug development, biomarker identification and efficacy analysis. Preclinical imaging enables understanding disease mechanisms and assists in developing personalized medicines through non-invasive quantification of biologic processes at cellular and molecular level over time.
Major players in the market have been expanding globally with focus on emerging markets in Asia Pacific and Latin America. For instance, Bruker Corporation partnered with labs in China and India to strengthen its preclinical imaging product distribution network in Asia. Mediso also extended its product portfolio through strategic acquisitions to expand globally.
Market Key Trends
The increased adoption of multimodal preclinical imaging systems is a key trend in the market. Multimodal systems integrate multiple preclinical imaging modalities such as optical, nuclear and MRI to provide anatomical, functional and molecular information. This helps researchers obtain comprehensive data from a single scan and study diverse biologic aspects leading to better decision making in drug development. Major players have launched new multimodal preclinical imaging systems to capitalize on this trend.
Porter’s Analysis
Threat of new entrants: Moderate barriers for new players to enter due to high capital requirements.
Bargaining power of buyers: Buyers have low bargaining power due to limited availability of substitutes.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to differentiated products and services.
Threat of new substitutes: Low threat of substitutes as preclinical imaging offers non-invasive technique for research.
Competitive rivalry: High as major players compete on basis of technology, price and quality.
Geographical Regions
North America accounts for the largest share of the global Preclinical Imaging Market. This is attributed to growing research activities in oncology and increasing R&D investments. Asia Pacific is expected to grow at the fastest pace during the forecast period driven by emerging countries like China and India.
Geographical Regions
Europe is the second largest regional market for preclinical imaging dominated by Germany, France and UK. Substantial funding for research in academia and pharmaceutical industry are propelling market growth. Japan also contributes significant value share owing to aging population and demand for non-invasive diagnostics.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
